600351 亚宝药业
已收盘 10-16 15:00:00
资讯
新帖
简况
股市必读：亚宝药业新发布《亚宝药业集团股份有限公司关于以集中竞价交易方式回购股份的进展公告》
证券之星 · 10-12
股市必读：亚宝药业新发布《亚宝药业集团股份有限公司关于以集中竞价交易方式回购股份的进展公告》
亚宝药业（600351）10月9日主力资金净买入2369.75万元
证券之星 · 10-10
亚宝药业（600351）10月9日主力资金净买入2369.75万元
亚宝药业(600351)9月30日股东户数4.79万户，较上期增加0.9%
证券之星 · 10-09
亚宝药业(600351)9月30日股东户数4.79万户，较上期增加0.9%
亚宝药业：公司积极关注并努力尝试AI技术在各个业务板块的运用
证券之星 · 10-09
亚宝药业：公司积极关注并努力尝试AI技术在各个业务板块的运用
亚宝药业：截止2026年9月20日，公司股东总户数为47,427户
证券之星 · 10-09
亚宝药业：截止2026年9月20日，公司股东总户数为47,427户
亚宝药业：公司将严格按照《上市公司股份回购规则》《上海证券交易所上市公司自律监管指引第 7 号——回购股份》等相关规定，在回购期限内根据市场情况择机做出回购决策并予以实施
证券之星 · 10-09
亚宝药业：公司将严格按照《上市公司股份回购规则》《上海证券交易所上市公司自律监管指引第 7 号——回购股份》等相关规定，在回购期限内根据市场情况择机做出回购决策并予以实施
股市必读：亚宝药业新发布《亚宝药业集团股份有限公司关于以集中竞价交易方式回购股份的进展公告》
证券之星 · 10-09
股市必读：亚宝药业新发布《亚宝药业集团股份有限公司关于以集中竞价交易方式回购股份的进展公告》
亚宝药业（600351）9月29日主力资金净卖出910.77万元
证券之星 · 09-30
亚宝药业（600351）9月29日主力资金净卖出910.77万元
9月21日亚宝药业涨5.14%，华富匠心明选一年持有混合A基金重仓该股
证券之星 · 09-21
9月21日亚宝药业涨5.14%，华富匠心明选一年持有混合A基金重仓该股
每周股票复盘：亚宝药业（600351）首次回购股份20万股
证券之星 · 09-13
每周股票复盘：亚宝药业（600351）首次回购股份20万股
股市必读：亚宝药业（600351）9月8日董秘有最新回复
证券之星 · 09-09
股市必读：亚宝药业（600351）9月8日董秘有最新回复
股市必读：亚宝药业（600351）8月31日董秘有最新回复
证券之星 · 09-01
股市必读：亚宝药业（600351）8月31日董秘有最新回复
亚宝药业：截止2026年8月20日，公司股东总户数为50,358户
证券之星 · 08-31
亚宝药业：截止2026年8月20日，公司股东总户数为50,358户
股市必读：亚宝药业新发布《亚宝药业集团股份有限公司关于2026年半年度权益分派实施后调整回购价格上限的公告》
证券之星 · 08-31
股市必读：亚宝药业新发布《亚宝药业集团股份有限公司关于2026年半年度权益分派实施后调整回购价格上限的公告》
每周股票复盘：亚宝药业（600351）现机构净买入968.71万元
证券之星 · 08-30
每周股票复盘：亚宝药业（600351）现机构净买入968.71万元
股市必读：亚宝药业新发布《亚宝药业集团股份有限公司2026年半年度权益分派实施公告》
证券之星 · 08-27
股市必读：亚宝药业新发布《亚宝药业集团股份有限公司2026年半年度权益分派实施公告》
亚宝药业（600351）披露2026年半年度权益分派实施公告，8月25日股价上涨3.24%
证券之星 · 08-25
亚宝药业（600351）披露2026年半年度权益分派实施公告，8月25日股价上涨3.24%
每周股票复盘：亚宝药业（600351）拟回购股份不少于1亿
证券之星 · 08-23
每周股票复盘：亚宝药业（600351）拟回购股份不少于1亿
股市必读：亚宝药业新发布《亚宝药业集团股份有限公司关于向全资子公司增资的进展暨完成工商变更登记的公告》
证券之星 · 08-21
股市必读：亚宝药业新发布《亚宝药业集团股份有限公司关于向全资子公司增资的进展暨完成工商变更登记的公告》
股市必读：亚宝药业新发布《北京市中勤律师事务所关于亚宝药业集团股份有限公司2026年第三次临时股东会律师见证法律意见书》
证券之星 · 08-20
股市必读：亚宝药业新发布《北京市中勤律师事务所关于亚宝药业集团股份有限公司2026年第三次临时股东会律师见证法律意见书》
加载更多
公司概况
公司名称：
亚宝药业集团股份有限公司
所属行业：
医药制造业
上市日期：
2002-09-26
主营业务：
亚宝药业集团股份有限公司的主营业务是药品及大健康产品的研发、生产和销售。公司的主要产品是丁桂儿脐贴、薏芽健脾凝胶、儿童清咽解热口服液、甲钴胺片、盐酸倍他司汀注射液、红花注射液、硝苯地平缓释片、唯源素、唯源泰、唯源全。
发行价格：
4.80
{"stockData":{"symbol":"600351","market":"SH","secType":"STK","nameCN":"亚宝药业","latestPrice":6.84,"timestamp":1792134000000,"preClose":6.89,"halted":0,"volume":34281860,"delay":0,"changeRate":-0.0073,"floatShares":692000000,"shares":692000000,"eps":0.4671,"marketStatus":"已收盘","change":-0.05,"latestTime":"10-16 15:00:00","open":6.92,"high":7.13,"low":6.75,"amount":240000000,"amplitude":0.0552,"askPrice":6.85,"askSize":600,"bidPrice":6.84,"bidSize":118,"shortable":0,"etf":0,"ttmEps":0.4671,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1792373400000},"marketStatusCode":5,"adr":0,"adjPreClose":6.89,"symbolType":"stock","openAndCloseTimeList":[[1792114200000,1792121400000],[1792126800000,1792134000000]],"highLimit":7.58,"lowLimit":6.2,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":692000046,"isCdr":false,"pbRate":1.68,"roa":"--","peRate":14.643545,"roe":"6.25%","epsLYR":0.46,"committee":0.314417,"marketValue":4733000000,"turnoverRate":0.0495,"status":1,"floatMarketCap":4733000000},"requestUrl":"/m/hq/s/600351","defaultTab":"news","newsList":[{"id":"2674406843","title":"股市必读：亚宝药业新发布《亚宝药业集团股份有限公司关于以集中竞价交易方式回购股份的进展公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2674406843","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674406843?lang=zh_cn&edition=full","pubTime":"2026-10-12 01:17","pubTimestamp":1791739027,"startTime":"0","endTime":"0","summary":"公司公告汇总亚宝药业集团股份有限公司关于以集中竞价交易方式回购股份的进展公告亚宝药业于2026年8月18日召开2026年第三次临时股东会，审议通过回购股份方案，拟以集中竞价交易方式回购股份，资金总额不低于1亿元且不超过2亿元，回购价格不超过6.75元/股，回购期限为2026年8月18日至2027年8月17日，回购股份用于减少注册资本；截至2026年9月30日，已累计回购748,900股，占公司总股本的0.11%，支付金额4,999,373.00元，成交价区间为6.58元/股至6.74元/股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101200000410.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","600351","BK0077","BK0028","BK0096","BK0201"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674986705","title":"亚宝药业（600351）10月9日主力资金净买入2369.75万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2674986705","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674986705?lang=zh_cn&edition=full","pubTime":"2026-10-10 08:17","pubTimestamp":1791591472,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年10月9日收盘，亚宝药业报收于7.07元，上涨3.67%，换手率5.67%，成交量39.22万手，成交额2.74亿元。近5日资金流向一览见下表：亚宝药业融资融券信息显示，融资方面，当日融资买入1762.18万元，融资偿还2161.1万元，融资净偿还398.92万元。亚宝药业主营业务：公司主要从事药品的研发、生产和销售,现有产品涵盖中西药制剂、贴敷剂、原料药和药用包装材料等共计300多个品种。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101000003869.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0028","BK0077","BK0201","600351","BK0096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674914830","title":"亚宝药业(600351)9月30日股东户数4.79万户，较上期增加0.9%","url":"https://stock-news.laohu8.com/highlight/detail?id=2674914830","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674914830?lang=zh_cn&edition=full","pubTime":"2026-10-09 17:30","pubTimestamp":1791538256,"startTime":"0","endTime":"0","summary":"证券之星消息，近日亚宝药业披露，截至2026年9月30日公司股东户数为4.79万户，较9月20日增加426.0户，增幅为0.9%。在中药行业个股中，亚宝药业股东户数低于行业平均水平，截至9月30日，中药行业平均股东户数为5.22万户。从股价来看，2026年9月20日至2026年9月30日，亚宝药业区间涨幅为3.18%，在此期间股东户数增加426.0户，增幅为0.9%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026100900027159.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0201","600351","BK0096","BK0239","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674831598","title":"亚宝药业：公司积极关注并努力尝试AI技术在各个业务板块的运用","url":"https://stock-news.laohu8.com/highlight/detail?id=2674831598","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674831598?lang=zh_cn&edition=full","pubTime":"2026-10-09 15:33","pubTimestamp":1791531221,"startTime":"0","endTime":"0","summary":"证券之星消息，亚宝药业(600351)10月09日在投资者关系平台上答复投资者关心的问题。投资者提问：目前AI在创新药领域发展迅猛，公司有没有计划在创新方面引入AI技术？亚宝药业回复：投资者您好，公司积极关注并努力尝试AI技术在各个业务板块的运用。本文数据来源于上海证券交易所e互动，仅供参考不构成投资建议。责任编辑：沈彬","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026100900018901.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0201","BK0239","BK0077","BK0096","BK0028","600351"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674183137","title":"亚宝药业：截止2026年9月20日，公司股东总户数为47,427户","url":"https://stock-news.laohu8.com/highlight/detail?id=2674183137","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674183137?lang=zh_cn&edition=full","pubTime":"2026-10-09 15:33","pubTimestamp":1791531207,"startTime":"0","endTime":"0","summary":"证券之星消息，亚宝药业(600351)10月09日在投资者关系平台上答复投资者关心的问题。投资者提问：请问截止至2026年9月20日公司股东人数是多少亚宝药业回复：投资者您好，截止2026年9月20日，公司股东总户数为47,427户。本文数据来源于上海证券交易所e互动，仅供参考不构成投资建议。责任编辑：陈思雨","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026100900018888.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0096","BK0077","600351","BK0201","BK0239","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674831551","title":"亚宝药业：公司将严格按照《上市公司股份回购规则》《上海证券交易所上市公司自律监管指引第 7 号——回购股份》等相关规定，在回购期限内根据市场情况择机做出回购决策并予以实施","url":"https://stock-news.laohu8.com/highlight/detail?id=2674831551","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674831551?lang=zh_cn&edition=full","pubTime":"2026-10-09 15:33","pubTimestamp":1791531204,"startTime":"0","endTime":"0","summary":"证券之星消息，亚宝药业(600351)10月09日在投资者关系平台上答复投资者关心的问题。投资者提问：公司目前回购价上限为6.75元，如果后续股价高于上限导致回购不能按时完成，，公司是否会考虑提高回购价上限以完成计划？亚宝药业回复：投资者您好，公司将严格按照《上市公司股份回购规则》《上海证券交易所上市公司自律监管指引第 7 号——回购股份》等相关规定，在回购期限内根据市场情况择机做出回购决策并予以实施。本文数据来源于上海证券交易所e互动，仅供参考不构成投资建议。责任编辑：沈彬","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026100900018885.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","600351","BK0096","BK0028","BK0239","BK0201"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674023720","title":"股市必读：亚宝药业新发布《亚宝药业集团股份有限公司关于以集中竞价交易方式回购股份的进展公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2674023720","media":"证券之星","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674023720?lang=zh_cn&edition=full","pubTime":"2026-10-09 02:35","pubTimestamp":1791484511,"startTime":"0","endTime":"0","summary":"公司公告汇总亚宝药业集团股份有限公司关于以集中竞价交易方式回购股份的进展公告亚宝药业于2026年8月18日召开2026年第三次临时股东会，审议通过回购股份方案，拟以集中竞价交易方式回购股份，资金总额不低于1亿元且不超过2亿元，回购价格不超过6.75元/股，回购期限为2026年8月18日至2027年8月17日，回购股份用于减少注册资本。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026100900002398.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0096","BK0077","600351","BK0239","BK0201"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671322573","title":"亚宝药业（600351）9月29日主力资金净卖出910.77万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2671322573","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671322573?lang=zh_cn&edition=full","pubTime":"2026-09-30 08:31","pubTimestamp":1790728309,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年9月29日收盘，亚宝药业报收于6.7元，下跌1.9%，换手率2.51%，成交量17.4万手，成交额1.17亿元。近5日资金流向一览见下表：亚宝药业融资融券信息显示，融资方面，当日融资买入1353.45万元，融资偿还966.55万元，融资净买入386.9万元。亚宝药业主营业务：公司主要从事药品的研发、生产和销售,现有产品涵盖中西药制剂、贴敷剂、原料药和药用包装材料等共计300多个品种。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026093000006749.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0201","BK0028","BK0239","BK0096","600351"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669159357","title":"9月21日亚宝药业涨5.14%，华富匠心明选一年持有混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2669159357","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669159357?lang=zh_cn&edition=full","pubTime":"2026-09-21 16:37","pubTimestamp":1789979864,"startTime":"0","endTime":"0","summary":"证券之星消息，9月21日亚宝药业涨5.14%，收盘报6.95元，换手率4.3%，成交量29.72万手，成交额2.03亿元。重仓亚宝药业的公募基金请见下表：根据2026基金半年报公募基金重仓股数据，重仓该股的公募基金共2家，其中持有数量最多的公募基金为华富基金的华富匠心明选一年持有混合A。华富匠心明选一年持有混合A的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092100020768.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","600351","BK0239","BK0201","BK0096","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667507416","title":"每周股票复盘：亚宝药业（600351）首次回购股份20万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2667507416","media":"证券之星","labels":["buyback"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667507416?lang=zh_cn&edition=full","pubTime":"2026-09-13 02:26","pubTimestamp":1789237571,"startTime":"0","endTime":"0","summary":"截至2026年9月11日收盘，亚宝药业报收于6.63元，较上周的6.66元下跌0.45%。本周，亚宝药业9月8日盘中最高价报7.1元。亚宝药业当前最新总市值45.88亿元，在中药板块市值排名43/66，在两市A股市值排名3362/5218。本次回购基于2026年8月18日股东会审议通过的回购方案，回购资金总额预计为1亿元至2亿元，回购股份用于减少注册资本，实施期限为2026年8月18日至2027年8月17日，资金来源为公司自有资金。回购价格上限因2026年半年度权益分派调整为6.75元/股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091300000625.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0096","BK0077","600351","BK0239","BK0201"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666372845","title":"股市必读：亚宝药业（600351）9月8日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2666372845","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666372845?lang=zh_cn&edition=full","pubTime":"2026-09-09 01:25","pubTimestamp":1788888317,"startTime":"0","endTime":"0","summary":"截至2026年9月8日收盘，亚宝药业报收于7.01元，上涨4.78%，换手率4.34%，成交量30.01万手，成交额2.07亿元。董秘最新回复投资者： 股价已经低于6.75元，公司可以回购了吗？你这种回购方案是不是符合上市公司回购的要求。这么多公司回购，只有你一家，这个方案是比较独特的。当日关注点交易信息汇总：9月8日主力资金净流入999.97万元，占总成交额4.83%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090900002264.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0239","BK0201","BK0096","600351","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664000945","title":"股市必读：亚宝药业（600351）8月31日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2664000945","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664000945?lang=zh_cn&edition=full","pubTime":"2026-09-01 02:40","pubTimestamp":1788201623,"startTime":"0","endTime":"0","summary":"截至2026年8月31日收盘，亚宝药业报收于7.12元，下跌2.06%，换手率4.05%，成交量28.04万手，成交额1.99亿元。本次实施权益分派的股权登记日为2026 年 8 月 31 日，除权除息日为 2026 年 9 月 1 日。故因为除权除息，回购上限回购股份价格上限由不超过人民币 6.95 元/股（含）调整为不超过人民币 6.75 元/股（含），调整后的回购价格上限自 2026 年9 月 1 日起生效。董秘： 投资者您好，截止2026年8月20日，公司股东总户数为50,358户。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090100002488.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600351","BK0096","BK0201","BK0239","BK0077","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663073976","title":"亚宝药业：截止2026年8月20日，公司股东总户数为50,358户","url":"https://stock-news.laohu8.com/highlight/detail?id=2663073976","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663073976?lang=zh_cn&edition=full","pubTime":"2026-08-31 16:12","pubTimestamp":1788163930,"startTime":"0","endTime":"0","summary":"证券之星消息，亚宝药业(600351)08月31日在投资者关系平台上答复投资者关心的问题。投资者提问：请问截止8月10日，公司最新的股东人数是多少？谢谢！亚宝药业回复：投资者您好，截止2026年8月20日，公司股东总户数为50,358户。本文数据来源于上海证券交易所e互动，仅供参考不构成投资建议。责任编辑：刘浩然","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026083100020243.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0201","BK0077","BK0028","BK0096","600351"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663164047","title":"股市必读：亚宝药业新发布《亚宝药业集团股份有限公司关于2026年半年度权益分派实施后调整回购价格上限的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2663164047","media":"证券之星","labels":["buyback"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663164047?lang=zh_cn&edition=full","pubTime":"2026-08-31 05:41","pubTimestamp":1788126071,"startTime":"0","endTime":"0","summary":"截至2026年8月28日收盘，亚宝药业报收于7.27元，上涨0.97%，换手率3.72%，成交量25.71万手，成交额1.87亿元。当日关注点交易信息汇总：8月28日主力资金净流入948.62万元，占总成交额5.09%。公司公告汇总：亚宝药业因实施2026年半年度权益分派，自9月1日起将回购价格上限由6.95元/股调整为6.75元/股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026083100001420.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","600351","BK0201","BK0028","BK0096","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663100530","title":"每周股票复盘：亚宝药业（600351）现机构净买入968.71万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2663100530","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663100530?lang=zh_cn&edition=full","pubTime":"2026-08-30 04:29","pubTimestamp":1788035348,"startTime":"0","endTime":"0","summary":"截至2026年8月28日收盘，亚宝药业报收于7.27元，较上周的6.87元上涨5.82%。本周，亚宝药业8月28日盘中最高价报7.33元。交易信息汇总8月26日亚宝药业发生1笔大宗交易，机构净买入968.71万元。本次利润分配以公司总股本692,000,046股为基数，共计派发现金红利138,400,009.20元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026083000001378.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0096","BK0077","600351","BK0201","BK0239","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662574498","title":"股市必读：亚宝药业新发布《亚宝药业集团股份有限公司2026年半年度权益分派实施公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2662574498","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662574498?lang=zh_cn&edition=full","pubTime":"2026-08-27 04:16","pubTimestamp":1787775372,"startTime":"0","endTime":"0","summary":"截至2026年8月26日收盘，亚宝药业报收于7.17元，上涨2.43%，换手率5.17%，成交量35.74万手，成交额2.55亿元。公司公告汇总：亚宝药业披露2026年半年度权益分派方案，每股派发现金红利0.2元（含税），股权登记日为2026年8月31日，现金红利发放日为2026年9月1日。大宗交易8月26日亚宝药业发生1笔大宗交易，机构净买入968.71万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082700009646.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","600351","BK0077","BK0028","BK0096","BK0201"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662536257","title":"亚宝药业（600351）披露2026年半年度权益分派实施公告，8月25日股价上涨3.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662536257","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662536257?lang=zh_cn&edition=full","pubTime":"2026-08-25 22:34","pubTimestamp":1787668450,"startTime":"0","endTime":"0","summary":"截至2026年8月25日收盘，亚宝药业报收于7.0元，较前一交易日上涨3.24%，最新总市值为48.44亿元。该股当日开盘6.75元，最高7.02元，最低6.64元，成交额达1.7亿元，换手率为3.54%。近日，亚宝药业集团股份有限公司发布《2026年半年度权益分派实施公告》：每股派发现金红利0.2元（含税），股权登记日为2026年8月31日，除权（息）日为2026年9月1日，现金红利发放日为2026年9月1日。本次利润分配以公司总股本692,000,046股为基数，共计派发现金红利138,400,009.20元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082500051199.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","600351","BK0096","BK0028","BK0201","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661211187","title":"每周股票复盘：亚宝药业（600351）拟回购股份不少于1亿","url":"https://stock-news.laohu8.com/highlight/detail?id=2661211187","media":"证券之星","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661211187?lang=zh_cn&edition=full","pubTime":"2026-08-23 02:00","pubTimestamp":1787421637,"startTime":"0","endTime":"0","summary":"截至2026年8月21日收盘，亚宝药业报收于6.87元，较上周的6.97元下跌1.43%。本周关注点公司公告汇总：亚宝药业拟以不低于1亿元且回购股份将用于注销并减资。增资后，亚宝生物注册资本由8,000万元增至18,000万元。亚宝药业集团股份有限公司于2026年8月18日召开2026年第三次临时股东会，审议通过以集中竞价交易方式回购股份的方案。回购股份将依法注销并减少注册资本。回购期限自股东会审议通过之日起不超过12个月。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082300000306.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0201","BK0077","BK0028","BK0096","600351"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661391232","title":"股市必读：亚宝药业新发布《亚宝药业集团股份有限公司关于向全资子公司增资的进展暨完成工商变更登记的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2661391232","media":"证券之星","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661391232?lang=zh_cn&edition=full","pubTime":"2026-08-21 04:09","pubTimestamp":1787256552,"startTime":"0","endTime":"0","summary":"截至2026年8月20日收盘，亚宝药业报收于7.15元，上涨2.29%，换手率4.74%，成交量32.81万手，成交额2.35亿元。当日关注点交易信息汇总：8月20日主力资金净流入21.81万元，占总成交额0.09%。公司公告汇总：全资子公司北京亚宝生物药业有限公司完成10,000万元增资的工商变更登记，注册资本由8,000万元增至18,000万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082100003999.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600351","BK0239","BK0077","BK0096","BK0201","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660984427","title":"股市必读：亚宝药业新发布《北京市中勤律师事务所关于亚宝药业集团股份有限公司2026年第三次临时股东会律师见证法律意见书》","url":"https://stock-news.laohu8.com/highlight/detail?id=2660984427","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660984427?lang=zh_cn&edition=full","pubTime":"2026-08-20 01:47","pubTimestamp":1787161673,"startTime":"0","endTime":"0","summary":"公司公告汇总北京市中勤律师事务所关于亚宝药业集团股份有限公司2026年第三次临时股东会律师见证法律意见书北京市中勤律师事务所就亚宝药业2026年第三次临时股东会的召集、召开程序、召集人资格、出席人员资格、表决程序及表决结果出具法律意见书。北京市中勤律师事务所出具法律意见书确认会议合法有效。亚宝药业集团股份有限公司通知债权人公告亚宝药业2026年第三次临时股东会审议通过以集中竞价交易方式回购股份方案。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082000001780.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","600351","BK0201","BK0028","BK0096","BK0239"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1792158570754,"stockEarnings":[{"period":"1week","weight":0.0103},{"period":"1month","weight":0.0408},{"period":"3month","weight":0.0806},{"period":"6month","weight":0.0954},{"period":"1year","weight":0.1017},{"period":"ytd","weight":0.1526}],"compareEarnings":[{"period":"1week","weight":-0.0274},{"period":"1month","weight":-0.0406},{"period":"3month","weight":-0.0151},{"period":"6month","weight":-0.0849},{"period":"1year","weight":-0.0523},{"period":"ytd","weight":-0.0659}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"亚宝药业集团股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"47853人(较上一季度增加0.90%)","perCapita":"14460股","listingDate":"2002-09-26","address":"山西省运城市芮城县富民路43号","registeredCapital":"69200万元","survey":" 亚宝药业集团股份有限公司的主营业务是药品及大健康产品的研发、生产和销售。公司的主要产品是丁桂儿脐贴、薏芽健脾凝胶、儿童清咽解热口服液、甲钴胺片、盐酸倍他司汀注射液、红花注射液、硝苯地平缓释片、唯源素、唯源泰、唯源全。","listedPrice":4.8},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"亚宝药业(600351)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供亚宝药业(600351)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"亚宝药业,600351,亚宝药业股票,亚宝药业股票老虎,亚宝药业股票老虎国际,亚宝药业行情,亚宝药业股票行情,亚宝药业股价,亚宝药业股市,亚宝药业股票价格,亚宝药业股票交易,亚宝药业股票购买,亚宝药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"亚宝药业(600351)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供亚宝药业(600351)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}